BIOTON aims to reinforce its position of a biotechnological company with a global reach.
The Company is able to pursue its strategic objectives of protecting Patients’ health and improving the quality of their lives by participating in research and development projects, promoting the expansion of its product portfolio and making well-informed business decisions.
BIOTON fulfils its stated mission by implementing strategies and development plans aimed at:
- reinforcing BIOTON's status on the Polish insulin market
- promoting BIOTON's insulin world-wide by maximising its share of the existing markets and entering new ones
- developing innovative, clinically important medicinal products, including biotechnological drugs developed by members of the BIOTON Group
- expanding BIOTON’s generic drug portfolio.
Contact for investors:
cc group sp zoo
tel.: +48 (22) 440 14 40, +48 697 613 020